F. Barry Bays, Director at TREACE MEDICAL CONCEPTS, INC. (TMCI), sold 37,600 shares at $23.99 ($902K) on 2022-12-08, disclosed to the SEC on 2022-12-09.
Open-market sale of $902k TMCI by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $23.97 | 9,061 | $217K | 24.1% |
| 2 | $23.97 | 9,061 | $217K | 24.1% |
| 3 | $23.99 | 9,739 | $234K | 25.9% |
| 4 | $23.99 | 9,739 | $234K | 25.9% |
| Total | $23.98 avg | 37,600 | $902K | 100% |
| Filing → |
| TMCI | SELL | 2023-04-13 | $4.5M | — | Filing → |
| TMCI | SELL | 2023-03-30 | $3.0M | — | Filing → |
| TMCI | SELL | 2023-03-15 | $646K | — | Filing → |